|
![]() |
AltaceThis page contains recent news articles, when available, and an overview of Altace but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Altace (when available) Ramipril is an angiotensin-converting enzyme (ACE) inhibitor similar to benazepril, fosinopril, and quinapril. An inactive prodrug, ramipril is converted to ramiprilat in the liver and is used to treat hypertension and heart failure, to reduce proteinuria and renal disease in patients with nephropathies, and to prevent stroke, myocardial infarction, and cardiac death in high-risk patients. Indicated for diuretics and digitalis in congestive heart failure as adjunctive therapy; prophylaxis in post MI. Mechanism Of Action: Ramiprilat, the active metabolite, competes with angiotensin I for binding at the angiotensin-converting enzyme, blocking the conversion of angiotensin I to angiotensin II. As angiotensin II is a vasoconstrictor and a negative-feedback mediator for renin activity, lower concentrations result in a decrease in blood pressure and an increase in plasma renin. Ramiprilat may also act on kininase II, an enzyme identical to ACE that degrades the vasodilator bradykinin. News Articles on Ramipril Weak medicine for an unhealthy system - May 30, 2008 I take a drug called Altace to lower my risk of cardiovascular troubles associated with diabetes. At the drugstore, my co-pay for Altace ran about $20 a Los Angeles Times, UPDATE 1-King Pharma profit falls as Altace sales dive - May 8, 2008 N: Quote, Profile, Research) posted a 24 percent drop in first-quarter profit on Thursday as sales of its Altace blood-pressure drug plunged due to Reuters India, Patent war: Lupin's US generic plan in trouble - May 28, 2008 MUMBAI: India's Lupin, which had won a patent challenge case against US-based King Pharmaceuticals and Sanofi-Aventis for blood pressure drug Altace will Times of India, King Pharmaceuticals Files Citizen Petition Relating to New Altace ... - May 27, 2008 Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, Reuters Pharma Blog Watch - May 27, 2008 In his blog, Aaron Barkoff discusses King Pharmaceutical’s citizen petition on its hypertension drug Altace. The company lost its patent rights to Altace FDA news (subscription), Lupin in good health - May 28, 2008 King Phrama has filed a citizen petition against company’s blood pressure drug Altace in US, reports TOI. It was trading with volumes of 25433 shares. Moneycontrol.com, DREAM: Rosiglitazone reduced diabetes, renal disease but increased ... - May 28, 2008 Investigators randomly assigned 5269 individuals to 15 mg per day of ramipril (Altace, King Pharmaceuticals) vs. placebo or 8 mg per day of rosiglitazone Endocrine Today, Barr Shares Sink On Weak Results - May 8, 2008 King Pharmaceuticals said first-quarter net income dropped 24% as the introduction of a generic rival to its top Altace blood pressure drug hurt sales. Wall Street Journal King Pharmaceuticals, Inc. Q1 2008 Earnings Call Transcript - May 8, 2008 This decrease was primarily due to the market entry of the first generic substitute for ALTACE in December 2007. We expect ALTACE net sales to significantly Seeking Alpha, ASK DR. WEIL: Counting on creatine? - May 13, 2008 I'm on glucophage, Lipitor, Altace and Wellbutrin, and I want to be sure this would be safe. A. Creatine is an important compound in muscle tissue — it's Lancaster Newspapers, King Pharma Q1 profit falls - quick facts - May 8, 2008 This decrease in revenues was primarily due to the market entry of the first generic substitute for ALTACE in December 2007. by RTT Staff Writer. RTT News, 2 ACE inhibitors associated with higher mortality risks - May 5, 2008 ...heart failure — enalapril (Vasotec) and captopril (Capoten) — were associated with 10%–15% higher mortality than ramipril (Altace) among older patients. EurekAlert (press release), King Pharmaceuticals Files Citizen Petition Relating to New Patent ... - May 27, 2008 Fundamental data is provided by Zacks Investment Research and market data is provided by AlphaTrade. All information provided "as is" for informational istockAnalyst.com, King Pharmaceuticals Reports First-Quarter 2008 Financial Results - May 8, 2008 This decrease was primarily due to the market entry of the first generic substitute for ALTACE ® (ramipril) in December 2007. Reported net earnings equaled Business Wire (press release), ALSO NOTED: Pfizer gets new cancer team to advance key drugs ... - May 16, 2008 Report > India's Lupin saw its stock leap on an FDA approval for its version of the Wyeth heart-failure and blood-pressure med Altace, aka ramipril. FiercePharma, ALSO NOTED: Botox slowdown doesn't dampen Allergan's Q1; Shandong ... - May 8, 2008 ...posted a year-over-year decline in first quarter revenues from $516 million to $432 million on generic competition for its blood pressure med Altace. FiercePharma, US FTC reports 14 deals to delay generics in '07 - May 23, 2008 Shire (nasdaq: SHPGY - news - people )'s attention deficit drug Adderall XR and King Pharmaceutical's high blood pressure medication Altace. Forbes, BUYINS.NET: (WYE) SqueezeTrigger Price is $43.778. There is ... - May 28, 2008 ...including EFFEXOR (marketed as EFEXOR internationally) and EFFEXOR XR; cardiovascular products, including ALTACE (co-promoted with King Pharmaceuticals, Trading Markets (press release), phentermine nexium phentermine nasonex altace - 23 Apr 2008 Save $$$ - phentermine nexium phentermine nasonex altace. RxDrugstore for you: phentermine nexium phentermine nasonex altace - Cheapest price here! dBTechno, Correction: Wyeth Q1 Profit Falls Hurt By Generic Competitions ... - Apr 22, 2008 Alliance revenue reflects revenue to Wyeth derived from sales of Enbrel in the United States and Canada, Altace and the CYPHER stent. RTT News, Zacks Analyst Blog Highlights: Walgreen Company, Wal-Mart, HEICO ... - Apr 17, 2008 The US Court of Appeals ruled in favor of Lupin which is seeking to bring a generic version of Altace to market. King's appeal for a rehearing was denied in Business Wire (press release), Wyeth Reports Earnings Results for the 2008 First Quarter - Apr 22, 2008 Advil 172 8% (1) Alliance revenue reflects revenue to Wyeth derived from sales of Enbrel (in the United States and Canada), Altace and the CYPHER stent. MSN Money Boehringer says hypertension drug Micardis shown to cut risk of ... - Apr 7, 2008 ...was shown in a trial to be as effective at preventing a range of heart diseases as the standard treatment Altace while triggering fewer side effects. Forbes, People's Pharmacy Use Milk of Magnesia for skin conditions - Apr 6, 2008 Q: I developed a dry cough soon after my doctor diagnosed me with hypertension and put me on Altace. I would cough until I would gag and throw up into my Houston Chronicle, New blood pressure drug has fewer side effects: study - Mar 31, 2008 After four and a half years of study, researchers found that temisartan (marketed as Micardis, Pritor or Kinzal) and ramipril (Tritace, Ramace or Altace) AFP Studies highlight existing BP meds - Apr 1, 2008 The study of more than 17000 patients with coronary artery disease or diabetes found no major differences between those treated with Altace/ramipril, FiercePharma, ACE inhibitor can substitute ARB in treatment of heart failure - Mar 31, 2008 According to a new study, ACE inhibitor ramipril (Altace) proved to be as effective as its more expensive competitor ARB telmisartan (Micardis). Pravda, King Pharmaceuticals' CEO gets 75 percent compensation boost - Apr 16, 2008 Circuit ruled for Indian drug maker Lupin Ltd. by finding patents for King's top-selling drug, the blood pressure medication Altace, were invalid. Houston Chronicle, Blood pressure drug Micardis cuts heart risk-study - Mar 31, 2008 They found the Boehringer Ingelheim drug Micardis, or telmisartan, worked as well as the ACE inhibitor ramipril, marketed in the United States as Altace by Guardian, Latest in business - Mar 26, 2008 ..."The dollar value of brand products losing patent last year was at an all-time high of $1.2 billion with two products alone, Altace and Effexor XR, Canada.com, New blood pressure drug shows fewer side effects - Mar 31, 2008 Ramipril is known as Altace, and is marketed by King Pharmaceuticals. The researchers also looked at whether a combination of the two drugs provided Toronto Star, ACE Inhibitor as Effective as More Expensive Blood Pressure Drug - Mar 31, 2008 ...found no major differences between those treated with the widely used ACE inhibitor ramipril (Altace) and those given the ARB telmisartan (Micardis). U.S. News & World Report, New weapon in heart attack war - Mar 31, 2008 Telmisartan is sold in Australia as Micardis, and ramipril is sold as Tritace, Ramace and Altace. A third of patients in the study were given daily doses of Melbourne Herald Sun, Women's muscles fade first - Mar 28, 2008 Two drugs alone - Altace (a blood pressure medication) and Effexor XR (an antidepressant) - account for 60 per cent of this figure. Globe and Mail, ACC: ARBs and ACE Inhibitors Equal Separately but Together They Fall - Apr 1, 2008 ...and the ACE inhibitor ramipril (Altace) seem equal for high-risk cardiovascular patients without heart failure, but combined they are bad bedfellows. MedPage Today, Hypertension Drugs Effective in Elderly - Apr 1, 2008 There are other angiotensin-converting enzyme (ACE) inhibitors which can probably be used, such as ramipril (Altace/Tritace/Ramace). Enews 2.0, Cold sores and fever blisters unsightly, but treatable - Apr 13, 2008 I'm on Glucophage, Lipitor, Altace and Wellbutrin, and I want to be sure this would be safe. A: Creatine is an important compound in muscle tissue - it's Vancouver Sun, King Pharmaceuticals Announces ALTACE(R) Tablets Launch - Feb 15, 2008 King Pharmaceuticals, Inc. (NYSE: KG) announced today the launch of its new ALTACE® Tablets (ramipril). King has received orders and initiated shipments of WELT ONLINE, King launches Altace in tablet form - Feb 15, 2008 N: Quote, Profile, Research) said on Friday that it has begun selling its Altace blood pressure medicine in a new tablet form. The drugmaker said it will Reuters King Pharma Launches Altace Tablets - Update - Feb 15, 2008 2/15/2008 5:54:41 PM King Pharmaceuticals, Inc. (KG) said Friday that it has launched its key blood pressure drug Altace in a new tablet form. RTT News, UPDATE 1-King Pharma posts higher profit - Feb 28, 2008 Sales of its Altace blood-pressure drug fell 13 percent to $158 million, while sales of its muscle relaxant Skelaxin were basically flat at $114 million. Reuters King Pharmaceuticals Post Profit Increase For Fourth Quarter and 2007 - Feb 28, 2008 The job reductions, primarily to King’s sales force, followed a September decision by the US Court of Appeals that opened Altace, King’s flagship blood TriCities.com, Pharmacare to cover 120 more generic drugs - Feb 28, 2008 For example, generic blood pressure medication Ramipril costs about half as much as prescription drug Altace; Altace costs about $33.60 a month while Winnipeg Free Press, 2/15/2008 5:50:07 PM FairPoint Communications Inc. (FRP) announced ... - Feb 15, 2008 2/15/2008 5:27:20 PM King Pharmaceuticals, Inc. (KG) on Friday announced the launch its new Altace tablets and said that it will continue to make available RTT News, King Pharmaceuticals Reports Year-End and Fourth-Quarter 2007 ... - Feb 28, 2008 ALTACE(R) (ramipril) net sales totaled $158 million during the fourth quarter and $646 million for the year ended December 31, 2007, compared to $181 Centre Daily Times, List of causes for acute hives is long - Feb 18, 2008 ACE inhibitors include Vasotec, enalapril, captopril, Accupril, Altace and Mavik. If you are not sure about your medicine's safety with potassium, Kingston Daily Freeman, Sector Wrap: Key Drug Makers Decline - Jan 15, 2008 Analysts Tuesday said a new generic version of King Pharma's blood pressure drug Altace is starting to hurt the branded drug's results. CNNMoney.com Part D Plans Raise Drug Prices - Jan 22, 2008 Seventy-five percent of Part D drug plans in California, New York, Illinois, Florida and Texas raised prices on ramipril, which is marketed as Altace; AAFP News Now Quitman Junior High To Begin Drug Testing - Jan 16, 2008 27 after ingesting the prescription drug Altace brought to school by a student. One boy was transported to Children's Medical Center Dallas later that week Tyler Morning Telegraph, Wyeth Q4 Profit Up On Strong Drug Sales - Jan 31, 2008 Alliance revenue fell 13% to $321 million, hit by lower alliance revenue associated with sales of the CYPHER stent and Altace. The decline was partially RTT News, Wyeth Reports Earnings Results for the 2007 Fourth Quarter and ... - Jan 31, 2008 8% 684 10% (1) Alliance revenue reflects revenue to Wyeth derived from sales of Enbrel (in the United States and Canada), Altace and the CYPHER stent. PR Newswire (press release), King Pharma rises on patent settlement - Jan 8, 2008 ...is also being challenged, and in September, a court overturned a patent supporting the company's top drug, the blood pressure medication Altace. BusinessWeek BUYINS.NET: (WYE) SqueezeTrigger Price is $47.721. There is ... - Jan 9, 2008 ...including EFFEXOR (marketed as EFEXOR internationally) and EFFEXOR XR; cardiovascular products, including ALTACE (co-promoted with King Pharmaceuticals, Trading Markets (press release), Find full information of generic altace drug used in the treatment ... - Dec 14, 2007 2007-12-14 12:13:15 - Generic altace used to treat hypertension is a hypotensive agent. Generic for altace ramparil is also used to reduce heart attacks and PR-Inside.com (Pressemitteilung), King Pharma: Petition for rehearing denied in Altace case - Dec 3, 2007 ...based company filed the petition following the court's decision in September regarding the validity of a composition of matter patent for Altace, CNNMoney.com King Pharma says petition for rehearing on Altace ruling denied - Dec 3, 2007 ...appeals court denied its petition for rehearing on a ruling that the patent on its biggest product, high blood pressure medicine Altace, was invalid. Reuters Benchmark King Pharmaceuticals' Performance against Key Rivals - Nov 29, 2007 2001-06 26 Revenue and growth rate vs. peer set 27 Product analysis, 2001-06 29 Growth drivers 29 Skelaxin 29 Altace 30 Thrombin-JMI 30 Sonata 30 Growth Reuters King Pharma options up on takeover talk - Nov 30, 2007 King's top two drugs are Altace, a treatment for high blood pressure and the muscle relaxer Skelaxin. The company's shares rose 2.42 percent, or 25 cents, Reuters King Pharmaceuticals Reports Petition for Rehearing and Rehearing ... - Dec 3, 2007 5061722, a composition of matter patent for ALTACE® (ramipril). The decision applied the recent US Supreme Court decision in the KSR International v. WELT ONLINE, Quitman Student Still In Hospital - Dec 1, 2007 Quitman Police Chief Bill Wansley said the drug used was Altace, a high blood pressure medication, in 10 milligram blue capsules. “One student brought nine Tyler Morning Telegraph, Blood Pressure Drug Telmisartan Shows Powerful Activity Against ... - Dec 16, 2007 In this case, his team tested two drugs—telmisartan and an ACE inhibitor, ramipril (Altace)—in a rat model long favored by stroke researchers. Science Daily (press release) Court Denies King Pharma's Petition For Rehearing And Rehearing En ... - Dec 3, 2007 ...following the Court's decision in September regarding the validity of United States Patent, a composition of matter patent for Altace or ramipril. Trading Markets (press release), Quitman Junior High Prescription Drugs Identified - Nov 30, 2007 Friday police said the students took a blood pressure medicine called "Altace". Officers said one student brought nine of these capsules from home into KLTV, Quitman Students Took Heart Medication - Nov 30, 2007 Nine capsules of the drug Altace were passed around at Quitman Middle School on Tuesday. The six students who took it were hospitalized after experiencing Tyler Morning Telegraph, Add drug coverage to seniors' shopping list - Dec 14, 2007 The drugs looked at were Lipitor for high cholesterol, Zoloft for depression, Celebrex for arthritis, and Altace and the generic Nifedipine for high blood Fort Worth Star Telegram, Choose with caution: Drug plans more expensive next year - Dec 9, 2007 ...the arthritis drug Celebrex, 200 mg; the depression drug Zoloft, 100 mg; the blood pressure drug Altace, 10 mg; and the angina drug Nifedipine, 30 mg. Urbana/Champaign News-Gazette, 2008 Pharmaceutical Pipeline Is Not Expected to Produce ... - Nov 29, 2007 GlaxoSmithKline's migraine treatment Imitrex (sumatriptan succinate) and King Pharmaceuticals Inc.'s high blood pressure drug Altace (ramipril), Atlantic Information Services, Inc., BUYINS.NET: (WYE) SqueezeTrigger Price is $46.961. There is ... - Nov 27, 2007 ...including EFFEXOR (marketed as EFEXOR internationally) and EFFEXOR XR; cardiovascular products, including ALTACE (co-promoted with King Pharmaceuticals, Trading Markets (press release), Brand Names/Synonyms: Altace is also known by the following brand names and/or synonymsAcovil; Altace; Carasel; Cardace; Delix; HOE 498; Hytren; Lostapres; Pramace; Quark; Ramace; Ramipril; Ramipril [Usan:Ban:Inn]; Ramiprilum [Latin]; Triatec; Tritace; Unipril; Vesdil Drug Category: Altace is categorized under the following by the FDA: Antihypertensive Agents; Angiotensin-converting Enzyme Inhibitors; ATC:C09AA05 Dosage Forms: CAPSULE Absorption: The extent of absorption is at least 50-60% and is not significantly influenced by the presence of food in the GI tract, although the rate of absorption is reduced. Interactions: Interactions for Ramipril: With nonsteroidal anti-inflammatory agents: Rarely, concomitant treatment with ACE inhibitors and nonsteroidal anti-inflammatory agents have been associated with worsening of renal failure and an increase in serum potassium. With Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with ramipril. The possibility of hypotensive effects with ramipril can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with ramipril. If this is not possible, the starting dose should be reduced. With Potassium Supplements and Potassium-sparing Diuretics: Ramipril can attenuate potassium loss caused by thiazide diuretics. Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia. Therefore, if concomitant use of such agents is indicated, they should be given with caution, and the patient's serum potassium should be monitored frequently. With Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium. These drugs should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended. If a diuretic is also used, the risk of lithium toxicity may be increased. Other: Neither ramipril nor its metabolites have been found to interact with food, digoxin, antacid, furosemide, cimetidine, indomethacin, and simvastatin. The combination of ramipril and propranolol showed no adverse effects on dynamic parameters (blood pressure and heart rate). The co-administration of ramipril and warfarin did not adversely affect the anticoagulant effects of the latter drug. Additionally, co-administration of ramipril with phenprocoumon did not affect minimum phenprocoumon levels or interfere with the subjects' state of anti-coagulation. Chemical IUPAC Name: 4-[2-(1-ethoxycarbonyl-3-phenyl-propyl)aminopropanoyl]-4-azabicyclo[3.3.0]octane-3-carboxylicacid : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |